Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participants - reply to Fussenich et al.: a new, simple and objective prognostic score for phase I cancer patients
Eur J Cancer
.
2012 Mar;48(4):594-6.
doi: 10.1016/j.ejca.2011.11.004.
Epub 2011 Dec 7.
Authors
David Olmos
,
Joo Ern Ang
,
Carlos Gomez-Roca
,
Rafael Morales-Barrera
,
Annelie J Vulink
,
Christophe Massard
,
Stan Kaye
;
EDDN
Collaborators
EDDN
:
David Olmos
,
Joo Ern Ang
,
T Brunetto
,
Stan Kaye
,
Rafael Morales-Barrera
,
Jordi Rodon
,
Josep Tabernero
,
Carlos Gomez-Roca
,
Christophe Massard
,
Jean-Charles Soria
,
Annelie J Vulink
,
Emile E Voest
,
Jaap Verweij
,
Jan H Schellens
,
Patrick Schoffski
,
Nicolas Penel
,
Silvia Marsoni
,
Gianluca del Conte
,
Luca Gianni
,
Cristiana Sessa
,
Jeff Evans
,
Richard Wilson
,
Ruth Plummer
PMID:
22154652
DOI:
10.1016/j.ejca.2011.11.004
No abstract available
Publication types
Letter
Comment
MeSH terms
Clinical Trials, Phase I as Topic / methods*
Female
Humans
Male
Medical Oncology / standards*